Dennis M. McGrath’s vast executive management experience in private and public companies. Currently he serves as the President and CFO of PAVmed, Inc. (Nasdaq: PAVM), a diversified commercial-stage medical technology company and as the Chief Financial Officer of Lucid Diagnostics, Inc. (Nasdaq: LUCD), a PAVmed subsidiary, since the consummation of Lucid’s initial public offering. In addition, he serves as the audit and/or compensation committee chair of several public and private biopharmaceutical and medical device companies including Dario Health (Nasdaq: DRIO), Citius Pharma (Nasdaq: CTXR) and Citius Oncology (Nasdaq: CTOR).